Gonadotropin releasing hormone agonist treatment for severe menorrhagia in patients with contraindications to surgery

Paolo Vercellini, Augusto Ferrari, Alberto D'Alberton, Tiziano Motta, Renato Maggi, Piero Molteni

Research output: Contribution to journalArticle


Four patients with heavy menorrhagia, severe iron-deficiency anemia and contraindications to surgery were treated with a gonadotropin-releasing hormone agonist in a depot formulation. At 2 months of therapy they were all amenorrheic, and at 6 months the hematologic values had improved markedly. Gonadotropin-releasing hormone agonists may obviate emergency surgery in patients at high surgical risk or could constitute the first line of sequential therapeutic regimens, once general health conditions have improved.

Original languageEnglish
Pages (from-to)70-72
Number of pages3
JournalEuropean Journal of Obstetrics and Gynecology and Reproductive Biology
Issue number1
Publication statusPublished - Jun 16 1992



  • Gonadotropin releasing hormone agonist
  • Menorrhagia

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Reproductive Medicine

Cite this